Aristotle University Of Thessaloniki (AUTH)
Διερεύνηση των καταθλιπτικών συμπτωμάτων σε διαφορετικά στάδια της σχιζοφρένειας
Abstract
dc:descriptionDescriptions of varied clinical manifestations of schizophrenia and the acknowledgement of its heterogeneity prevail in the literature parallel to a continuous debate on whether schizophrenia constitutes a distinct nosological entity with unique aetiology and pathophysiology or a clinical syndrome (the schizophrenia spectrum) where different diseases with different aetiologies and pathophysiologies are manifested. Studies over the last years have focused on the identification of the dimensions of the psychopathology of schizophrenia and the symptom complexes which constitute them, demonstrating the depressive symptoms as an integral part of the illness. High prevalence of depressive symptoms in schizophrenia is interpreted by researchers as an indication of the relationship between schizophrenic and bipolar spectrum in the context of the conceptualization of a unitary model for major psychiatric disorders. During the last years depressive symptoms in schizophrenia have been in the centre of epidemiological, clinical and psychopharmacological studies, as their significance and their frequent emergence in all phases of the disorder have been acknowledged. Factors that could be related to the appearance of depressive symptoms in schizophrenia are explored from a genetic, pathophysiological, neuropsychological and psychosocial perspective. In addition, the secondary emergence of depression in relation to medical illnesses and the need for differential diagnosis from negative and extrapyramidal symptoms are pointed out. Specific research tools for the assessment of depressive symptoms in schizophrenia, like the Calgary Depression Scale for Schizophrenia, have been developed, in order to achieve better recognition and description of the depressive syndrome, and also its distinction from negative and extrapyramidal symptoms. The present study explored the relationship between depressive symptoms in schizophrenia, in different phases of the illness, and other psychopathological symptoms of the illness, medication side-effects, and socio-demographic and clinical characteristics of the patients. Depressive symptoms were assessed by Calgary Depression Scale for Schizophrenia and the subscale PANSS-D of the Positive and Negative Symptom Scale (PANSS). […]
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgiadou, Eleni
- Γεωργιάδου, Ελένη
Subjects
dc:subject × 20- Κατάθλιψη
- Καταθλιπτικά συμπτώματα
- Σχιζοφρένεια
- Προσωπικές πεποιθήσεις για τη νόσο
- Κλίμακα κατάθλιψης Calgary
- Εναισθησία
- Νευρογνωστικό έλλειμμα
- Μεγαψυχωγική κατάθλιψη
- Depsession
- Depressive symptoms
- Schizophrenia
- Personal beliefs about illness
- Insight
- Calgary depression scale for schizophrenia
- Neurocognitive deficit
- Postpsychotic depression
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19127